ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS

Extracorporeal Membrane Oxygenation for COVID-19 and Influenza H1N1 Associated Acute Respiratory Distress Syndrome: a Multi-centre Retrospective Cohort Study

Objective: Veno-venous ECMO has been used as a rescue therapy for patients with severe ARDS associated to influenza A H1N1 and COVID19 viral pneumonia. Little is known about outcome of these patients who required extracorporeal support.

Research question: To compare outcome of patients who required VV ECMO for Covid19 and H1N1 associated ARDS

Inclusion Criteria:

• COVID-19 or influenza A H1N1 (suspected or confirmed) diagnosis
• Severe ARDS (according to Berlin Definition)
• VV ECMO
• Invasive mechanical ventilation through endotracheal tube or tracheostomy

Exclusion Criteria:

• Age<18 years